Ahmed Mohamed M, Abo-Hager Eman A
Faculty of Dental Medicine, Al-Azhar University, Boys Branch, Egypt.
Saudi Dent J. 2010 Jan;22(1):27-34. doi: 10.1016/j.sdentj.2009.12.001. Epub 2010 Jan 4.
Adenoid cystic carcinoma (ACC) of the salivary gland is characterized by a prolonged but inevitably unfavorable clinical course. Recent studies have suggested that the transmembrane tyrosine kinase receptor, c-kit proto-oncogene is involved in ACC pathogenesis. CD43 is a sialoglycoprotein that is typically expressed by hematopoietic cells and their derivative neoplasms, although positivity in epithelial tumors has only been recognized recently.
The aim of this study was to evaluate c-kit and CD43 immunoreactivity in ACCs and to compare the extent of their expression in various histologically defined subgroups of ACC, and their probable involvement in ACC pathogenesis.
Formalin-fixed paraffin-embedded sections from 35 ACCs were immunostained for c-kit and CD43 using monoclonal antibodies.
Cytoplasmic and membranous c-kit immunoreactivity was detected in 25/35 ACCs (71.4%) with strong immunostaining observed in solid pattern of ACC. Cytoplasmic and membranous CD43 immunoreactivity was detected in 18/35 (51.4%) of ACCs with strong immunostaining seen in the cribriform pattern.
These results suggested that c-kit could be used as a prognostic marker for ACC and specific c-kit tyrosine kinase inhibitors such as imatinib, might be used in future therapeutic approaches against subgroups of ACC. CD43 appears to be preferentially expressed in salivary gland ACCs. Its expression decreased with cellular dedifferentiation and there was an inverse relationship between immunoexpression of c-kit and CD43 among ACC of salivary gland.
涎腺腺样囊性癌(ACC)的特点是病程较长,但最终预后不佳。最近的研究表明,跨膜酪氨酸激酶受体c-kit原癌基因参与了ACC的发病机制。CD43是一种唾液糖蛋白,通常由造血细胞及其衍生的肿瘤表达,尽管上皮性肿瘤中的阳性表达直到最近才被认识到。
本研究旨在评估ACC中c-kit和CD43的免疫反应性,并比较它们在ACC不同组织学定义亚组中的表达程度,以及它们可能在ACC发病机制中的作用。
使用单克隆抗体对35例ACC的福尔马林固定石蜡包埋切片进行c-kit和CD43免疫染色。
在25/35例(71.4%)ACC中检测到c-kit的胞质和膜免疫反应性,在ACC实体型中观察到强免疫染色。在18/35例(51.4%)ACC中检测到CD43的胞质和膜免疫反应性,在筛状型中可见强免疫染色。
这些结果表明,c-kit可作为ACC的预后标志物,特定的c-kit酪氨酸激酶抑制剂如伊马替尼,可能用于未来针对ACC亚组的治疗方法。CD43似乎在涎腺ACC中优先表达。其表达随细胞去分化而降低,在涎腺ACC中c-kit和CD43的免疫表达之间存在负相关。